With a panel of 32 bromodomain assays, bromoMAX includes the entire BET family along with other diverse bromodomains including ATAD2, BAZ2A, CREBBP, SMARCA2, PBRM1(5), TAF1L and others. This comprehensive collection of validated assays virtually eliminates assay development bottlenecks and provides a comprehensive selectivity screening tool that can accelerate the identification and optimization of potent and selective small molecule bromodomain inhibitors.
bromoMAX
Features
Features
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
